0001104659-17-037045.txt : 20170601 0001104659-17-037045.hdr.sgml : 20170601 20170601204921 ACCESSION NUMBER: 0001104659-17-037045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170530 FILED AS OF DATE: 20170601 DATE AS OF CHANGE: 20170601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Talbot George Harrison CENTRAL INDEX KEY: 0001554194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 17886226 MAIL ADDRESS: STREET 1: C/O DURATA THERAPEUTICS, INC. STREET 2: 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR CITY: MORRISTOWN STATE: NJ ZIP: 07960 4 1 a4.xml 4 X0306 4 2017-05-30 0 0001641640 Nabriva Therapeutics AG NBRV 0001554194 Talbot George Harrison 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 1 0 0 0 Common Shares 2017-05-30 4 S 0 110 101.50 D 3449 D Common Shares 2017-05-30 4 S 0 100 101.00 D 3349 D The common shares whose sale is reported on this line are represented by American Depositary Shares ("ADSs"). Each ADS represents one tenth (1/10) of a common share of Nabriva Therapeutics AG. The reporting person may hold both common shares and ADSs representing common shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of common shares. The price of $101.50 per common share was derived from the sale price on May 30, 2017, of $10.15 per ADS, multiplied by ten. The price of $101.00 per common share was derived from the sale price on May 30, 2017, of $10.10 per ADS, multiplied by ten. /s/ George Harrison Talbot 2017-06-01